Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ipidacrine (NIK‐247) (NIK‐247) is an Antidementia Agent
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 29.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Ipidacrine (NIK‐247) (NIK‐247) is an Antidementia Agent |
In vivo | A single oral administration of ipidacrine (0.3 and 1 mg/kg) reduced the increased total latency induced by scopolamine in this task.?The repeated administration of ipidacrine (1 mg/kg) of once a day for 5 successive days reduced the increased total latency induced by scopolamine to the levels of the saline-treated control rats in this task.Ipidacrine was rapidly taken up into the brain within 5 min. Moreover, higher drug levels were observed mainly in the cortex and hippocampus, which both play important roles in learning and memory.?Thus, a previous study together with this investigation indicate that ipidacrine improves amnesia which consists of the impairment of the working and reference memory in various animal models, suggesting that ipidacrine is a useful candidate for the therapy of patients with Alzheimer's disease[1]. |
Synonyms | NIK‐247 |
Molecular Weight | 188.27 |
Formula | C12H16N2 |
CAS No. | 62732-44-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (53.11 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ipidacrine 62732-44-9 Others inhibit NIK‐247 cholinesterase nootropic Inhibitor Cholinesterase (ChE) Alzheimer disease inhibitor